Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Systemic lupus erythematosus | R-HSA-977105 | map05322 | vincamine | 5280965 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | vincamine | 5280965 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | vincamine | 5280965 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | vincamine | 5280965 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | vincamine | 5280965 | drug-path |
Shigellosis | 0 | map05131 | vincamine | 5280965 | drug-path |
Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | vincamine | 5280965 | drug-path |
MAPK signaling pathway | R-HSA-9652817 | map04010 | vincamine | 5280965 | drug-path |
Gap junction | R-HSA-190861 | map04540 | vincamine | 5280965 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | thioguanosine | 4114 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | thioguanosine | 4114 | drug-path |
p53 signaling pathway | R-HSA-168638 | map04115 | thioguanosine | 4114 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | thioguanosine | 4114 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | thioguanosine | 4114 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | thioguanosine | 4114 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | thioguanosine | 4114 | drug-path |
Huntington's disease | R-HSA-1643685 | 0 | thioguanosine | 4114 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | thioguanosine | 4114 | drug-path |
Cell cycle | R-HSA-1640170 | map04110 | thioguanosine | 4114 | drug-path |
Jak-STAT signaling pathway | R-HSA-168638 | map04630 | thioguanosine | 4114 | drug-path |